Citizens Lifts PT on Sutro Biopharma (STRO) on Its Pipeline and Lead Program
Sutro Biopharma, Inc. (NASDAQ:STRO) is one of the best performing small cap stocks so far in 2026. Citizens lifted the price target on Sutro Biopharma, Inc.
Sutro Biopharma Inc. (STRO)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Biotechnology Value Fund / BVF Inc Mark Lampert | 1,251,788 | $31,182,039 | 0.99% | |
| 2. | Samsara BioCapital Srini Akkaraju And Michael Dybbs | 1,062,872 | $26,476,142 | +420% | 2.57% |
| 3. | Kynam Capital Derrick Tang | 872,558 | $21,735,420 | +82% | 1.34% |
| 4. | OrbiMed Advisors Samuel Isaly | 801,144 | $19,956,497 | 0.4% | |
| 5. | Perceptive Advisors Joseph Edelman | 715,307 | $17,818,297 | 0.35% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.80 | 17,000 | $13,606.80 | 71,832 | 2025-10-15 | Filing | |
| $0.81 | 19,750 | $15,997.50 | 19,750 | 2025-10-15 | Filing | |
| $0.80 | 12,500 | $10,011.25 | 122,850 | 2025-10-15 | Filing | |
| $0.80 | 50,000 | $39,950.00 | 50,000 | 2025-10-15 | Filing | |
| $0.80 | 12,504 | $9,993.20 | 71,737 | 2025-10-15 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.00 | 12,185 | $60,925.00 | 12,803 | 2024-01-29 | Filing | |
| $4.71 | 15,428 | $72,594.91 | 0 | 2023-08-28 | Filing | |
| $4.59 | 11,613 | $53,281.61 | 12,928 | 2023-08-25 | Filing | |
| $18.62 | 3,906 | $72,724.25 | 7,270 | 2021-09-28 | Filing | |
| $26.10 | 165 | $4,306.15 | 56,117 | 2021-01-26 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,069,519 | $26,641,718 | 1.38% | |
| 2. | 720,442 | $17,946,210 | 0% | |
| 3. | 715,307 | $17,818,297 | 0.29% | |
| 4. | 392,871 | $9,786,416 | 0% | |
| 5. | 272,351 | $6,784,263 | 1.94% |
News See All
10 Best Performing Small Cap Stocks So Far in 2026
Talking about the hiccup in tech, she was of the view that we are going to go through this over and over again, which includes worries about whether or not spending can keep up.
10 Tiny Stocks That Are On Fire Right Now
On April 16, Fundstrat’s Tom Lee joined 'Closing Bell' to argue that the stock market is currently in a stronger position than it was earlier in the year when it reached all-time highs.
15 Best U.S. Stocks to Buy Now Under $10
The U.S. has always been a financial and economic hub, home to some of the biggest companies in various sectors.
Ken Fisher's 12 New Stock Picks
Before we begin to see what Ken Fisher is up to in the context of latest market movements, let’s see a hugely important paragraph from Fisher’s hedge fund’s Q2’2023 report.
11 Best Biotech Penny Stocks to Buy Now
As investors begin to see light at the end of the tunnel, their risk appetite, which had vanished amid recession risks and volatility, is coming back, creating chances of major investments in high-risk...
Top 5 Stock Picks of Srini Akkaraju and Michael Dybbs' Samsara BioCapital
In this article, we discuss the top 5 stock picks of Srini Akkaraju and Michael Dybbs' Samsara BioCapital.
Is Sutro Biopharma, Inc. (STRO) Going to Burn These Hedge Funds?
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market reached another high in...
Should I Avoid Sutro Biopharma, Inc. (STRO)?
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilities...
15 Biotech Stocks to Buy Now According to Srini Akkaraju and Michael Dybbs' Samsara BioCapital
In this article, we will discuss 15 biotech stocks to buy now according to Srini Akkaraju and Michael Dybbs' Samsara BioCapital.
Hedge Fund Resource Center